M
Mario Venditti
Researcher at Sapienza University of Rome
Publications - 373
Citations - 13795
Mario Venditti is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Endocarditis & Intensive care unit. The author has an hindex of 56, co-authored 349 publications receiving 11551 citations. Previous affiliations of Mario Venditti include Policlinico Umberto I & University of Catania.
Papers
More filters
Journal ArticleDOI
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
Evelina Tacconelli,Maria Adriana Cataldo,Stephanie J. Dancer,G. De Angelis,Marco Falcone,Uwe Frank,Gunnar Kahlmeter,Angelo Pan,Nicola Petrosillo,Jesús Rodríguez-Baño,Jesús Rodríguez-Baño,N. Singh,Mario Venditti,Deborah S. Yokoe,Barry Cookson +14 more
TL;DR: The recommendations are presented in the form of 'basic' practices, recommended for all acute care facilities, and 'additional special approaches' to be considered when there is still clinical and/or epidemiological and molecular evidence of ongoing transmission, despite the application of the basic measures.
Journal ArticleDOI
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
Andrea Morelli,Christian Ertmer,Martin Westphal,Sebastian Rehberg,Tim Kampmeier,Sandra Ligges,Alessandra Orecchioni,Annalia D'Egidio,Fiorella D’Ippoliti,Cristina Raffone,Mario Venditti,Fabio Guarracino,Massimo Girardis,Luigi Tritapepe,Paolo Pietropaoli,Alexander Mebazaa,Mervyn Singer +16 more
TL;DR: Targeted heart rates were achieved in all patients in the esmolol group compared with those in the control group and no clinically relevant differences between groups in other cardiopulmonary variables nor in rescue therapy requirements were found.
Journal ArticleDOI
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belén Gutiérrez-Gutiérrez,Elena Salamanca,Marina de Cueto,Po-Ren Hsueh,Pierluigi Viale,José Ramón Paño-Pardo,Mario Venditti,Mario Tumbarello,George L. Daikos,Rafael Cantón,Yohei Doi,Felipe Francisco Tuon,Ilias Karaiskos,Elena Pérez-Nadales,Mitchell J. Schwaber,Mitchell J. Schwaber,Özlem Kurt Azap,Maria Souli,Emmanuel Roilides,Spyros Pournaras,Murat Akova,Federico Perez,Joaquín Bermejo,Antonio Oliver,Manel Almela,Warren Lowman,Benito Almirante,Robert A. Bonomo,Robert A. Bonomo,Yehuda Carmeli,Yehuda Carmeli,David L. Paterson,Álvaro Pascual,Álvaro Pascual,Jesús Rodríguez-Baño,Jesús Rodríguez-Baño,M.D. del Toro,Jorge Galvez,Marco Falcone,Alessandro Russo,Helen Giamarellou,Enrico Maria Trecarichi,Angela Raffaella Losito,E. García-Vázquez,Alicia Hernandez,J. Gómez,Germán Bou,Elias Iosifidis,N. Prim,Ferran Navarro,Beatriz Mirelis,Anna Skiada,Julia Origüen,R. San Juan,Mario Fernández-Ruiz,Nieves Larrosa,Mireia Puig-Asensio,José Miguel Cisneros,José Molina,V. González,V. Rucci,E. Ruiz de Gopegui,C. I. Marinescu,Luis Martínez-Martínez,M.C. Fariñas,M. E. Cano,Mónica Gozalo,Marta Mora-Rillo,C. Navarro-San Francisco,Carmen Peña,Silvia Gómez-Zorrilla,Fe Tubau,Athanassios Tsakris,O. Zarkotou,Anastasia Antoniadou,Garyphallia Poulakou,Johann D. D. Pitout,Deepali Virmani,J. Torre-Cisneros,Julia Guzmán-Puche,Ö. Helvaci,A. O. Sahin,Vicente Pintado,Patricia Cordero Ruiz,Michele Bartoletti,Maddalena Giannella,Evelina Tacconelli,F. Riemenschneider,Esther Calbo,Cristina Badia,M. Xercavins,Oriol Gasch,D. Fontanals,E. Jové +93 more
TL;DR: Patients with BSIs due to CPE should receive active therapy as soon as they are diagnosed, and monotherapy should be considered for those in the low-mortality-score stratum.
Journal ArticleDOI
Invasive Infections Caused by Trichosporon Species and Geotrichum capitatum in Patients with Hematological Malignancies: a Retrospective Multicenter Study from Italy and Review of the Literature
Corrado Girmenia,Livio Pagano,Bruno Martino,Domenico D'Antonio,Rosa Fanci,Giorgina Specchia,Lorella Melillo,Massimo Buelli,Giampaolo Pizzarelli,Mario Venditti,Pietro Martino +10 more
TL;DR: The optimal therapy for trichosporonosis has yet to be identified; however, in vitro experiences are providing encouraging evidence of the potential role of the new triazoles, in particular, voriconazole.
Journal ArticleDOI
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia.
TL;DR: In this paper, a multicenter, prospective observational study was conducted to ascertain the epidemiology and outcome of community-associated, health care-associated and hospital-acquired pneumonia in adults hospitalized in internal medicine wards.